{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:36:08Z","timestamp":1792794968016,"version":"4.5.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T00:00:00Z","timestamp":1640044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>STUDY QUESTION<\/jats:title>\n                    <jats:p>What is the prevalence of pre-eclampsia (PE) in pregnancies after oocyte donation (OD) compared to natural conception (NC) and to IVF with autologous oocytes (AO)?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SUMMARY ANSWER<\/jats:title>\n                    <jats:p>Overall the prevalence of PE after OD was 4\u20135 times higher than after NC and 2\u20133 times higher than after IVF with AO.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                    <jats:p>The indication for OD is expanding to lesbian women requesting shared lesbian motherhood. Previous reviews have shown that the risk of PE is higher in pregnancies after OD than after NC and after IVF with AO. Classification on the severity of PE is lacking as is the relationship with known risk factors such as maternal age and multiple gestations. Furthermore the actual prevalence of PE in pregnancies resulting from OD is not known.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                    <jats:p>A systematic review and meta-analysis was conducted. A literature search was performed using the following databases: PubMed, EMBASE and CINAHL, OpenGrey and Greynet from January 1980 through July 2020.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                    <jats:p>We included retrospective and prospective cohort studies. The study population consisted of pregnancies after OD and NC or IVF and data had to be available about prevalence of PE. We compared the risk of (severe) PE in OD versus NC and IVF pregnancies, subgrouped by plurality and maternal age. We calculated individual and pooled odds ratios (OR) and prevalence estimates with 95% CI using a random effect model, while heterogeneity was assessed by the I2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                    <jats:p>In total, 27 studies comprising of 7089 OD pregnancies, 1\u200a139\u200a540 NC pregnancies and 72\u200a742 IVF pregnancies were available for analysis. The risks of PE and severe PE was increased in OD pregnancies compared to NC pregnancies (pooled OR of all subgroups: 5.09, 95% CI: 4.29\u20136.04; I2 = 19% and OR: 7.42, 95% CI: 4.64\u201311.88; I2 = 49%, respectively). This suggests that compared to a PE risk of 2.9% with NC, the risk with OD was between 11.5% and 15.4%. Compared to a severe PE risk of 0.5% with NC, the risk with OD was between 2.3% and 5.6%. The pooled adjusted OR for PE was 3.24 (95% 2.74\u20133.83) for OD versus NC pregnancies. The risks of PE and severe PE were also increased in OD pregnancies compared to IVF pregnancies (pooled OR of all subgroups: 2.97, 95% CI: 2.49\u20133.53; I2 = 51% and OR: 2.97, 95% CI: 2.15\u20134.11; I2 = 0%, respectively). This suggests that compared to a PE risk of 5.9% with IVF, the risk with OD was between 13.5% and 18.0%. Compared to a severe PE risk of 3.3% with IVF, the risk with OD was between 6.8% and 12.2%. The pooled adjusted OR for PE was 2.67 (95% 2.28\u20133.13) for OD versus IVF. The pooled prevalence of PE in singleton pregnancies after OD was 10.7% (95% CI 6.6\u201315.5) compared to 2.0% (95% CI 1.0\u20133.1) after NC and 4.1% (95% CI 2.7\u20135.6) after IVF. The prevalence in multiple pregnancies was 27.8% (95% CI 23.6\u201332.2) after OD, 7.5% (95% CI 7.2\u20137.8) after NC and 9.7% (95% CI 6.2\u201313.9) after IVF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                    <jats:p>The precise definition of PE is still a matter of debate. The different criteria could have affected the prevalence estimate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                    <jats:p>Nearly one in six women will suffer PE after OD. Although it is uncertain whether these risks are consistent for lesbian couples undergoing shared motherhood, we feel that women who can conceive naturally could be advised to reconsider. In women with primary ovarian insufficiency, we feel that factors that may increase risk of PE ever further, such as double embryo transfer, should be avoided whenever possible.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY FUNDING\/COMPETING INTEREST(s)<\/jats:title>\n                    <jats:p>No funding or competing interests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>REGISTRATION NUMBER<\/jats:title>\n                    <jats:p>CRD42020166899.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/humrep\/deab267","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T23:52:47Z","timestamp":1637365967000},"page":"586-599","source":"Crossref","is-referenced-by-count":53,"title":["Pre-eclampsia in pregnancies resulting from oocyte donation, natural conception or IVF: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1646-2229","authenticated-orcid":false,"given":"A","family":"Keukens","sequence":"first","affiliation":[{"name":"Centre for Reproductive Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"van Wely","sequence":"additional","affiliation":[{"name":"Centre for Reproductive Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"van der Meulen","sequence":"additional","affiliation":[{"name":"Centre for Reproductive Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7299-6666","authenticated-orcid":false,"given":"M H","family":"Mochtar","sequence":"additional","affiliation":[{"name":"Centre for Reproductive Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,21]]},"reference":[{"key":"2022030206054648700_deab267-B1","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1007\/s10995-018-2525-y","article-title":"Mothers in same-sex relationships describe the process of forming a family as a stressful journey in a heteronormative world: a Swedish Grounded Theory Study","volume":"22","author":"Appelgren Engstrom","year":"2018","journal-title":"Matern Child Health J"},{"key":"2022030206054648700_deab267-B2","first-page":"131","article-title":"Pregnancies utilizing donated oocytes pose potential risks to recipients and neonates","volume":"64","author":"Barnard","year":"2019","journal-title":"J Reprod Med"},{"key":"2022030206054648700_deab267-B3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bpobgyn.2020.07.008","article-title":"Pregnancy outcomes following oocyte donation","volume":"70","author":"Berntsen","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2022030206054648700_deab267-B4","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s10815-016-0701-9","article-title":"Is oocyte donation a risk factor for preeclampsia? A systematic review and meta-analysis","volume":"33","author":"Bl\u00e1zquez","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"2022030206054648700_deab267-B5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.rbmo.2017.11.006","article-title":"Shared motherhood IVF: high delivery rates in a large study of treatments for lesbian couples using partner-donated eggs","volume":"36","author":"Bodri","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"2022030206054648700_deab267-B6","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1080\/14767058.2018.1533944","article-title":"Sainz A, Bartha JL. Impact of oocyte donation on obstetric and perinatal complications in twin pregnancies","volume":"33","author":"Boria","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2022030206054648700_deab267-B7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/09513590.2019.1653845","article-title":"Single or double embryo transfer? Decision-making process in patients participating in an oocyte donation program","volume":"36","author":"Clua","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"2022030206054648700_deab267-B8","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.rbmo.2012.09.008","article-title":"Elective single-embryo transfer in oocyte donation programmes: should it be the rule?","volume":"25","author":"Clua","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"2022030206054648700_deab267-B9","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1093\/humrep\/14.11.2755","article-title":"Donor age is paramount to success in oocyte donation","volume":"14","author":"Cohen","year":"1999","journal-title":"Hum Reprod"},{"key":"2022030206054648700_deab267-B10","doi-asserted-by":"crossref","first-page":"hoz038","DOI":"10.1093\/hropen\/hoz038","article-title":"ART in Europe, 2015: results generated from European registries by ESHRE","volume":"2020","author":"De Geyter","year":"2020","journal-title":"Hum Reprod Open"},{"key":"2022030206054648700_deab267-B11","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00404-017-4616-1","article-title":"Increased incidence of preeclampsia in mothers of advanced age conceiving by oocyte donation","volume":"297","author":"Dior","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"2022030206054648700_deab267-B12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12884-015-0687-9","article-title":"Adverse obstetric outcomes in pregnancies resulting from oocyte donation: a retrospective cohort case study in Sweden","volume":"15","author":"Elenis","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"key":"2022030206054648700_deab267-B13","first-page":"7","article-title":"Risk factors and effective management of preeclampsia","volume":"8","author":"English","year":"2015","journal-title":"Integr Blood Press Control"},{"key":"2022030206054648700_deab267-B14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.maturitas.2016.06.007","article-title":"The COMET (Core Outcome Measures in Effectiveness Trials) initiative","volume":"91","author":"Gargon","year":"2016","journal-title":"Maturitas"},{"key":"2022030206054648700_deab267-B15","doi-asserted-by":"crossref","first-page":"2008.e9\u201312","DOI":"10.1016\/j.fertnstert.2008.05.050","article-title":"Cryopreservation of a mother's oocytes for possible future use by her daughter with Turner syndrome: case report","volume":"90","author":"Gidoni","year":"2008","journal-title":"Fertil Steril"},{"key":"2022030206054648700_deab267-B16","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/humupd\/dmq017","article-title":"Clinical and immunologic aspects of egg donation pregnancies: a systematic review","volume":"16","author":"Hoorn van der","year":"2010","journal-title":"Hum Reprod Update"},{"key":"2022030206054648700_deab267-B17","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/AOG.0b013e3181fb8e59","article-title":"The role of embryonic origin in preeclampsia: a comparison of autologous in vitro fertilization and ovum donor pregnancies","volume":"116","author":"Klatsky","year":"2010","journal-title":"Obstet Gynecol"},{"key":"2022030206054648700_deab267-B18","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1093\/humrep\/deaa108","article-title":"Increased risk of severe maternal morbidity in women with twin pregnancies resulting from oocyte donation","volume":"35","author":"Korb","year":"2020","journal-title":"Hum Reprod"},{"key":"2022030206054648700_deab267-B19","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/humrep\/der469","article-title":"Association between oocyte donation and maternal and perinatal outcomes in women aged 43 years or older","volume":"27","author":"Le Ray","year":"2012","journal-title":"Hum Reprod"},{"key":"2022030206054648700_deab267-B20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/humrep\/del327","article-title":"Definite involuntary childlessness: associations between coping, social support and psychological distress","volume":"22","author":"Lechner","year":"2007","journal-title":"Hum Reprod"},{"key":"2022030206054648700_deab267-B21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.fertnstert.2016.03.031","article-title":"Hypertensive pathologies and egg donation pregnancies: results of a large comparative cohort study","volume":"106","author":"Letur","year":"2016","journal-title":"Fertil Steril"},{"key":"2022030206054648700_deab267-B22","doi-asserted-by":"crossref","first-page":"383.e1","DOI":"10.1016\/j.ajog.2014.03.044","article-title":"The \u2018immunologic theory\u2019 of preeclampsia revisited: a lesson from donor oocyte gestations","volume":"211","author":"Levron","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"2022030206054648700_deab267-B23","doi-asserted-by":"crossref","first-page":"544.e1","DOI":"10.1016\/j.ajog.2013.08.019","article-title":"Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease","volume":"209","author":"Lisonkova","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"2022030206054648700_deab267-B24","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/AOG.0000000000000472","article-title":"Maternal morbidity associated with early-onset and late-onset preeclampsia","volume":"124","author":"Lisonkova","year":"2014","journal-title":"Obstet Gynecol"},{"key":"2022030206054648700_deab267-B25","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.fertnstert.2013.01.128","article-title":"Perinatal outcomes in 375 children born after oocyte donation: a Danish national cohort study","volume":"99","author":"Malchau","year":"2013","journal-title":"Fertil Steril"},{"key":"2022030206054648700_deab267-B26","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/humrep\/deq008","article-title":"Sharing motherhood: biological lesbian co-mothers, a new IVF indication","volume":"25","author":"Marina","year":"2010","journal-title":"Hum Reprod"},{"key":"2022030206054648700_deab267-B27","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ajog.2015.11.020","article-title":"Oocyte donation pregnancies and the risk of preeclampsia or gestational hypertension: a systematic review and metaanalysis","volume":"214","author":"Masoudian","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"2022030206054648700_deab267-B28","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00404-019-05291-w","article-title":"Higher rate of early-onset preeclampsia in pregnancies following oocyte donation according to increasing maternal age","volume":"300","author":"Masturzo","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"2022030206054648700_deab267-B29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.rbmo.2019.10.017","article-title":"Impact of the mode of conception on gestational hypertensive disorders at very advanced maternal age","volume":"40","author":"Meyer","year":"2020","journal-title":"Reprod Biomed Online"},{"key":"2022030206054648700_deab267-B30","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s10815-019-01545-3","article-title":"Risk of ischemic placental disease is increased following in vitro fertilization with oocyte donation: a retrospective cohort study","volume":"36","author":"Modest","year":"2019","journal-title":"J Assist Reprod Genet"},{"key":"2022030206054648700_deab267-B31","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s10815-019-01552-4","article-title":"Risk of adverse perinatal outcomes after oocyte donation: a systematic review and meta-analysis","volume":"36","author":"Moreno-Sepulveda","year":"2019","journal-title":"J Assist Reprod Genet"},{"key":"2022030206054648700_deab267-B32","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/aogs.12904","article-title":"High risks of maternal and perinatal complications in singletons born after oocyte donation","volume":"95","author":"Nejdet","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2022030206054648700_deab267-B33","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/oxfordjournals.humrep.a138541","article-title":"The evolution and outcome of pregnancies from oocyte donation","volume":"9","author":"Pados","year":"1994","journal-title":"Hum Reprod"},{"key":"2022030206054648700_deab267-B34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention","volume":"145 (Suppl 1","author":"Poon","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"2022030206054648700_deab267-B35","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/uog.14918","article-title":"Placental volume and uterine artery Doppler evaluation at 11 + 0 to 13 + 6 weeks' gestation in pregnancies conceived with in-vitro fertilization: comparison between autologous and donor oocyte recipients","volume":"47","author":"Rizzo","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2022030206054648700_deab267-B36","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/09513590.2018.1528577","article-title":"Increased incidence of obstetric and perinatal complications in pregnancies achieved using donor oocytes and single embryo transfer in young and healthy women. A prospective hospital-based matched cohort study","volume":"35","author":"Rodriguez-Wallberg","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"2022030206054648700_deab267-B37","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1093\/humrep\/14.9.2268","article-title":"The influence of donated gametes on the incidence of hypertensive disorders of pregnancy","volume":"14","author":"Salha","year":"1999","journal-title":"Hum Reprod"},{"key":"2022030206054648700_deab267-B38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1472-6483(10)60855-3","article-title":"Oocyte and embryo donation 2006: reviewing two decades of innovation and controversy","volume":"12","author":"Sauer","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"2022030206054648700_deab267-B39","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/humupd\/dmw012","article-title":"Maternal and fetal outcomes in oocyte donation pregnancies","volume":"22","author":"Savasi","year":"2016","journal-title":"Hum Reprod Update"},{"key":"2022030206054648700_deab267-B40","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.fertnstert.2014.01.055","article-title":"Effect of oocyte donation on pregnancy outcomes in in vitro fertilization twin gestations","volume":"101","author":"Sekhon","year":"2014","journal-title":"Fertil Steril"},{"key":"2022030206054648700_deab267-B41","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","article-title":"Pre-eclampsia","volume":"365","author":"Sibai","year":"2005","journal-title":"Lancet"},{"key":"2022030206054648700_deab267-B42","first-page":"9","article-title":"Risk of preeclampsia and obstetric outcome in donor oocyte and autologous in vitro fertilization pregnancies","volume":"68","author":"Simeone","year":"2016","journal-title":"Minerva Ginecol"},{"key":"2022030206054648700_deab267-B43","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.fertnstert.2017.08.035","article-title":"Embryo cryopreservation and preeclampsia risk","volume":"108","author":"Sites","year":"2017","journal-title":"Fertil Steril"},{"key":"2022030206054648700_deab267-B44","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/humrep\/13.2.483","article-title":"Obstetric and perinatal outcome after oocyte donation: comparison with in-vitro fertilization pregnancies","volume":"13","author":"S\u00f6derstr\u00f6m-Anttila","year":"1998","journal-title":"Hum Reprod"},{"key":"2022030206054648700_deab267-B45","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"2022030206054648700_deab267-B46","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1477-7827-10-42","article-title":"Obstetric outcome in donor oocyte pregnancies: a matched-pair analysis","volume":"10","author":"Stoop","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"2022030206054648700_deab267-B47","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/1471-0528.14257","article-title":"Obstetric and neonatal complications in pregnancies conceived after oocyte donation: a systematic review and meta-analysis","volume":"124","author":"Storgaard","year":"2017","journal-title":"Bjog"},{"key":"2022030206054648700_deab267-B48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.rbmo.2016.10.002","article-title":"Does oocyte donation compared with autologous oocyte IVF pregnancies have a higher risk of preeclampsia?","volume":"34","author":"Tarlatzi","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"2022030206054648700_deab267-B49","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3109\/14767058.2013.777422","article-title":"Perinatal outcomes in oocyte donor pregnancies","volume":"26","author":"Tranquilli","year":"2013","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2022030206054648700_deab267-B50","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejogrb.2014.09.019","article-title":"Pregnancy outcome of non-anonymous oocyte donation: a case\u2013control study","volume":"182","author":"van Dorp","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2022030206054648700_deab267-B51","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.ajog.2005.02.059","article-title":"Outcomes of pregnancies achieved by donor egg in vitro fertilization\u2013a comparison with standard in vitro fertilization pregnancies","volume":"192","author":"Wiggins","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"2022030206054648700_deab267-B52","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4103\/jhrs.JHRS_115_17","article-title":"Comparison of obstetric outcomes of pregnancies after donor-oocyte in vitro fertilization and self-oocyte in vitro fertilization: a retrospective cohort study","volume":"11","author":"Yadav","year":"2018","journal-title":"J Hum Reprod Sci"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/3\/586\/42673931\/deab267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/3\/586\/42673931\/deab267.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T01:09:55Z","timestamp":1646183395000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/37\/3\/586\/6472729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,21]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,12,21]]},"published-print":{"date-parts":[[2022,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deab267","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3,1]]},"published":{"date-parts":[[2021,12,21]]}}}